181 related articles for article (PubMed ID: 8040111)
1. Comparative in-vitro activity of biapenem against enterobacteria with beta-lactamase-mediated antibiotic resistance.
Chen HY; Livermore DM
J Antimicrob Chemother; 1994 Mar; 33(3):453-64. PubMed ID: 8040111
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
Chen HY; Livermore DM
J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068
[TBL] [Abstract][Full Text] [Related]
3. Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactams.
Babini GS; Yuan M; Livermore DM
Antimicrob Agents Chemother; 1998 May; 42(5):1168-75. PubMed ID: 9593145
[TBL] [Abstract][Full Text] [Related]
4. Interactions of meropenem with class I chromosomal beta-lactamases.
Yang YJ; Livermore DM
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():207-17. PubMed ID: 2808208
[TBL] [Abstract][Full Text] [Related]
5. Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases.
Mushtaq S; Ge Y; Livermore DM
Antimicrob Agents Chemother; 2004 Apr; 48(4):1313-9. PubMed ID: 15047535
[TBL] [Abstract][Full Text] [Related]
6. Activity of temocillin and other penicillins against beta-lactamase-inducible and -stably derepressed enterobacteria.
Yang Y; Livermore DM
J Antimicrob Chemother; 1988 Sep; 22(3):299-306. PubMed ID: 3263354
[TBL] [Abstract][Full Text] [Related]
7. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases.
Yang Y; Bhachech N; Bush K
J Antimicrob Chemother; 1995 Jan; 35(1):75-84. PubMed ID: 7768785
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal beta-lactamase expression and resistance to beta-lactam antibiotics in Proteus vulgaris and Morganella morganii.
Yang YJ; Livermore DM
Antimicrob Agents Chemother; 1988 Sep; 32(9):1385-91. PubMed ID: 3058021
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of cefpirome against beta-lactamase-inducible and stably derepressed Enterobacteriaceae.
Binfiglio G; Stefani S; Nicoletti G
Chemotherapy; 1994; 40(5):311-6. PubMed ID: 7956454
[TBL] [Abstract][Full Text] [Related]
10. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms.
Livermore DM; Yang YJ
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657
[TBL] [Abstract][Full Text] [Related]
11. Interactions of FCE 22101 with class I beta-lactamases.
Yang Y; Livermore DM
J Antimicrob Chemother; 1989 Mar; 23 Suppl C():85-94. PubMed ID: 2786519
[TBL] [Abstract][Full Text] [Related]
12. Activity of biapenem (RPX2003) combined with the boronate β-lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae.
Livermore DM; Mushtaq S
J Antimicrob Chemother; 2013 Aug; 68(8):1825-31. PubMed ID: 23580564
[TBL] [Abstract][Full Text] [Related]
13. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of biapenem against beta-lactamase producing Enterobacteriaceae.
Alonso R; Fernández-Aranguiz A; Colom K; Morla A; Suinaga E; Umaran A; Cisterna R
Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):820-2. PubMed ID: 7889951
[TBL] [Abstract][Full Text] [Related]
15. [in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases].
Martínez-Beltrán J; Calderón C; Sierra MP; Alvarez M; Cantón R
Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():20-6. PubMed ID: 9410065
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338.
Neu HC; Novelli A; Chin NX
Antimicrob Agents Chemother; 1989 Jul; 33(7):1009-18. PubMed ID: 2789493
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity and beta-lactamase stability of LJC 10,627.
Neu HC; Gu JW; Fang W; Chin NX
Antimicrob Agents Chemother; 1992 Jul; 36(7):1418-23. PubMed ID: 1510436
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of biapenem, a new carbapenem antibiotic.
Clarke AM; Zemcov SJ
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):377-84. PubMed ID: 8354306
[TBL] [Abstract][Full Text] [Related]
19. Meropenem: activity against resistant gram-negative bacteria and interactions with beta-lactamases.
Sanders CC; Sanders WE; Thomson KS; Iaconis JP
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():187-96. PubMed ID: 2808207
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of Biapenem plus RPX7009, a carbapenem combined with a serine β-lactamase inhibitor, against anaerobic bacteria.
Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
Antimicrob Agents Chemother; 2013 Jun; 57(6):2620-30. PubMed ID: 23529731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
